Hepion Pharmaceuticals Statistics
Total Valuation
HEPA has a market cap or net worth of $3.16 million. The enterprise value is $5.65 million.
Important Dates
The next estimated earnings date is Tuesday, May 20, 2025, after market close.
| Earnings Date | May 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HEPA has 10.98 million shares outstanding. The number of shares has increased by 54.75% in one year.
| Current Share Class | 10.98M |
| Shares Outstanding | 10.98M |
| Shares Change (YoY) | +54.75% |
| Shares Change (QoQ) | +3.70% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 0.53% |
| Float | 10.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | -1.69 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.51
| Current Ratio | 0.51 |
| Quick Ratio | 0.13 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15.51 |
Financial Efficiency
Return on equity (ROE) is -487.03% and return on invested capital (ROIC) is -283.62%.
| Return on Equity (ROE) | -487.03% |
| Return on Assets (ROA) | -122.71% |
| Return on Invested Capital (ROIC) | -283.62% |
| Return on Capital Employed (ROCE) | 1,264.36% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$599,655 |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.97M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.56% in the last 52 weeks. The beta is 1.80, so HEPA's price volatility has been higher than the market average.
| Beta (5Y) | 1.80 |
| 52-Week Price Change | -99.56% |
| 50-Day Moving Average | 2.88 |
| 200-Day Moving Average | 24.06 |
| Relative Strength Index (RSI) | 21.09 |
| Average Volume (20 Days) | 9,767,496 |
Short Selling Information
The latest short interest is 647,389, so 5.90% of the outstanding shares have been sold short.
| Short Interest | 647,389 |
| Short Previous Month | 199,814 |
| Short % of Shares Out | 5.90% |
| Short % of Float | 5.90% |
| Short Ratio (days to cover) | 0.06 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -19.35M |
| Pretax Income | -41.90M |
| Net Income | -13.19M |
| EBITDA | -19.32M |
| EBIT | -19.35M |
| Earnings Per Share (EPS) | -$107.35 |
Full Income StatementBalance Sheet
The company has $406,408 in cash and $2.90 million in debt, giving a net cash position of -$2.49 million or -$0.23 per share.
| Cash & Cash Equivalents | 406,408 |
| Total Debt | 2.90M |
| Net Cash | -2.49M |
| Net Cash Per Share | -$0.23 |
| Equity (Book Value) | -1.86M |
| Book Value Per Share | -25.57 |
| Working Capital | -1.53M |
Full Balance SheetCash Flow
| Operating Cash Flow | -18.22M |
| Capital Expenditures | n/a |
| Free Cash Flow | -18.22M |
| FCF Per Share | -$1.66 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |